secwatch.observer — SEC 8-K summary
======================================

Issuer:     GRAIL, Inc. (GRAL)
CIK:        0001699031
Form:       8-K
Filed at:   2025-02-20T23:59:59+00:00
Accession:  0001699031-25-000016
Event type: earnings
Sentiment:  neutral
Materiality: 0.55
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

GRAIL Q4 rev $38.3M (+26%), net loss $97.1M; FY Galleri rev $108.6M (+45%); adds TRICARE coverage
--------------------------------------------------------------------------------

- Q4 total revenue $38.3M (+26% YoY); Q4 Galleri revenue $31.6M (+39% YoY).
- Full year 2024 total revenue $125.6M (+35% YoY); Galleri revenue $108.6M (+45% YoY).
- Q4 net loss $97.1M including $34.6M amortization; full year net loss $2.0B incl $1.4B goodwill impairment.
- Non-GAAP adjusted EBITDA: Q4 ($84.0M), full year ($483.5M); cash position $767M, runway into 2028.
- TRICARE added Galleri as covered benefit for 50+ patients; registrational studies completed, PMA submission planned H1 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1699031/000169903125000016/0001699031-25-000016-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1699031/000169903125000016/gral-20250220.htm
  HTML page:      https://secwatch.observer/filing/0001699031-25-000016

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer